121 related articles for article (PubMed ID: 11518645)
21. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
Newman-Tancredi A; Chaput C; Verrièle L; Millan MJ
Eur J Pharmacol; 1996 Jun; 307(1):107-11. PubMed ID: 8831111
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
23. Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists.
Larsson LG; Stenfors C; Ross SB
Eur J Pharmacol; 1998 Apr; 346(2-3):209-15. PubMed ID: 9652362
[TBL] [Abstract][Full Text] [Related]
24. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse.
Patel S; Hutson PH
Eur J Pharmacol; 1996 Dec; 317(2-3):197-204. PubMed ID: 8997601
[TBL] [Abstract][Full Text] [Related]
25. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
Cervo L; Mocaër E; Bertaglia A; Samanin R
Neuropharmacology; 2000 Apr; 39(6):1037-43. PubMed ID: 10727714
[TBL] [Abstract][Full Text] [Related]
26. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
Dupuis DS; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
[TBL] [Abstract][Full Text] [Related]
27. Effects of aging on 5-HT(1A) receptors and their functional response to 5-HT(1a) agonist in the living brain: PET study with [carbonyl-(11)C]WAY-100635 in conscious monkeys.
Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Harada N
Synapse; 2001 Dec; 42(4):242-51. PubMed ID: 11746722
[TBL] [Abstract][Full Text] [Related]
28. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
29. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
Hedlund PB; Kelly L; Mazur C; Lovenberg T; Sutcliffe JG; Bonaventure P
Eur J Pharmacol; 2004 Mar; 487(1-3):125-32. PubMed ID: 15033384
[TBL] [Abstract][Full Text] [Related]
30. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.
Vinod KY; Subhash MN; Srinivas BN
Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737
[TBL] [Abstract][Full Text] [Related]
31. Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio schedule.
Ho MY; Body S; Kheramin S; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2003 May; 167(2):137-44. PubMed ID: 12655461
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of 5-HT1A receptor ligands by drug discrimination.
Wolff MC; Leander JD
Eur J Pharmacol; 1997 Aug; 333(2-3):113-22. PubMed ID: 9314023
[TBL] [Abstract][Full Text] [Related]
33. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
[TBL] [Abstract][Full Text] [Related]
34. Selectively bred male rat lines differ in naïve and experienced sexual behavior.
Sura A; Overstreet DH; Marson L
Physiol Behav; 2001 Jan; 72(1-2):13-20. PubMed ID: 11239976
[TBL] [Abstract][Full Text] [Related]
35. Memory of an operant response and of depressed mood retained in activation states of 5-HT(1A) receptors: evidence from rodent models.
Colpaert FC; Bruins Slot LA; Koek W; Dupuis DS
Behav Brain Res; 2000 Dec; 117(1-2):41-51. PubMed ID: 11099756
[TBL] [Abstract][Full Text] [Related]
36. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors.
Lima L; Laporte AM; Gaymard C; Spedding M; Mocaër E; Hamon M
J Neural Transm (Vienna); 1997; 104(10):1059-75. PubMed ID: 9503258
[TBL] [Abstract][Full Text] [Related]
37. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
[TBL] [Abstract][Full Text] [Related]
38. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
39. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
Alper RH; Nelson DL
Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
[TBL] [Abstract][Full Text] [Related]
40. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
